Perioperative anaphylaxis: progress, prevention and pholcodine policy

Affiliations

¹ Chair, Australian and New Zealand Anaesthetic Allergy Group Chair, Anaesthetic Allergy Subcommittee of the ANZCA Safety & Quality Committee.
² Chair, Mortality Subcommittee of ANZCA Safety & Quality Committee Chair, Victorian Consultative Council on Anaesthetic Mortality and Morbidity.

Editorial

P T McAleer et al. Anaesth Intensive Care. 2017 Mar.

. 2017 Mar;45(2):147-150.

doi: 10.1177/0310057X1704500203.

¹ Chair, Australian and New Zealand Anaesthetic Allergy Group Chair, Anaesthetic Allergy Subcommittee of the ANZCA Safety & Quality Committee.
² Chair, Mortality Subcommittee of ANZCA Safety & Quality Committee Chair, Victorian Consultative Council on Anaesthetic Mortality and Morbidity.

No abstract available

Comment on

The pholcodine story.
Florvaag E, Johansson SG. Florvaag E, et al. Immunol Allergy Clin North Am. 2009 Aug;29(3):419-27. doi: 10.1016/j.iac.2009.04.002. Immunol Allergy Clin North Am. 2009. PMID: 19563989
The Pholcodine Case. Cough Medicines, IgE-Sensitization, and Anaphylaxis: A Devious Connection.
Florvaag E, Johansson SG. Florvaag E, et al. World Allergy Organ J. 2012 Jul;5(7):73-8. doi: 10.1097/WOX.0b013e318261eccc. World Allergy Organ J. 2012. PMID: 23283141 Free PMC article.